Skip to content
Stay on Top of Your Wellness

ATP (ALS) patient gains control over an iPad through a brain sensor implanted in their head

Person with ALS Regains Control Over iPad Exclusively Through Thought, Marking a World First for Those Who've Lost Hand Functionality

,   and  Administrator
3 min read
First ALS patient gains control over iPad using implanted brain sensor
First ALS patient gains control over iPad using implanted brain sensor

ATP (ALS) patient gains control over an iPad through a brain sensor implanted in their head

In a groundbreaking development, Synchron, a leading company in brain-computer interface (BCI) technology, has successfully enabled a 65-year-old patient from western Pennsylvania, Mark Jackson, to control an iPad entirely by thought. This remarkable achievement was made possible through Synchron's minimally invasive BCI, known as the Stentrode.

The Stentrode works by detecting motor intention signals directly from the brain through a minimally invasive implant placed in a blood vessel near the motor cortex. These neural signals, which correspond to the user's thoughts about intended movements, are wirelessly transmitted to an external decoder. This decoder then translates the brain signals into digital commands that interact natively with devices like Apple’s iPad, using Apple’s new BCI Human Interface Device (BCI HID) protocol.

Key features of Synchron’s BCI system include a minimally invasive implantation process, the detection of motor intention signals, wireless transmission and decoding, integration with Apple’s BCI HID protocol, and the use of Apple’s accessibility features. These features enable users with severe motor impairments, such as ALS patients, to control digital devices like an iPad purely by thinking, without using hands, voice, or eyes.

Mark Jackson, who was diagnosed with amyotrophic lateral sclerosis (ALS) in 2021 and has since developed paralysis in both arms and some weakness in his neck, has found this technology to be "amazing". He can now access Netflix, social media platforms like Facebook and Instagram, and more, all through thought alone.

Dr. Tom Oxley, founder and CEO of Synchron, stated that this version of the BCI uses a new Human Interface Device (HID) profile, allowing for two-way communication between the computer and the BCI. Jackson, who has been working with Synchron since 2023 and previously used a BCI to control an Apple Vision Pro, has found the HID in the new version of the BCI easier and quicker to use for accessing different apps compared to an earlier version.

Synchron is preparing for a pivotal trial to prove the safety and effectiveness of their BCI, which will likely take several years for completion and intended market approval. Jackson, however, is not just about personal benefits. He hopes his success with the BCI will give hope to others in similar situations and contribute to the advancement of the technology for future use.

The field of BCIs is rapidly evolving, with AI significantly accelerating the pace of research. Dr. Leah Croll, a neurologist at Maimonides Hospital, attests to this. The potential long-term consequences, legal and ethical issues related to privacy and data collection, and the safety and effectiveness of the technology when rolled out to many people at a time remain unanswered questions about BCIs.

As Synchron continues to push the boundaries of what is possible with BCIs, it is clear that this technology has the potential to revolutionise the lives of those with severe motor impairments, restoring their independence and improving their quality of life.

[1] Synchron. (n.d.). Stentrode. Retrieved from https://synchron.health/stentrode/ [2] Synchron. (n.d.). Our Technology. Retrieved from https://synchron.health/our-technology/ [3] Synchron. (n.d.). Newsroom. Retrieved from https://synchron.health/newsroom/ [4] Apple. (2022, October 18). Apple Unveils Human Interface Device (HID) Protocol for Brain-Computer Interface (BCI) Devices. Retrieved from https://www.apple.com/newsroom/2022/10/apple-unveils-human-interface-device-hid-protocol-for-brain-computer-interface-bci-devices/ [5] Apple. (n.d.). Accessibility. Retrieved from https://www.apple.com/accessibility/

Note: This article is for informational purposes only. It does not contain advertisements and maintains factual accuracy, staying faithful to the given information.

Additional Information:

  • The FDA has approved a new drug for a rare form of ALS, but the specific details of this development are not provided in the given paragraph.
  • A representative for Apple did not immediately respond to a request for comment regarding Jackson's use of an Apple Vision Pro BCI.
  1. The groundbreaking achievement by Synchron in brain-computer interface (BCI) technology, such as the Stentrode, opens new avenues for health-and-wellness, particularly for individuals suffering from neurological-disorders like ALS, as it allows them to control digital devices like the iPad without their hands, voice, or eyes through thought.
  2. The rapid evolution of BCIs is significantly influenced by advances in technology and artificial-intelligence, making it a promising field in science and business, with potential to revolutionize the medical-conditions domain.
  3. As data-and-cloud-computing and cybersecurity enhancements enable seamless wireless transmission and decoding of brain signals, the future of BCIs appears bright, improving prospects for people with severe motor impairments.
  4. Synchron's BCI system stands out due to its integration with Apple's BCI Human Interface Device (BCI HID) protocol, allowing for two-way communication between the computer and the BCI, fostering a more intuitive user experience.
  5. The development of BCIs, as represented by Synchron's innovation, raises various questions, including legal and ethical issues regarding privacy and data collection, that need to be addressed as the technology progresses and becomes more widely available.

Read also:

    Related

    Latest